PortfoliosLab logoPortfoliosLab logo
COLL vs. CRWD
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

COLL vs. CRWD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Collegium Pharmaceutical, Inc. (COLL) and CrowdStrike Holdings, Inc. (CRWD). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

COLL vs. CRWD - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
COLL
Collegium Pharmaceutical, Inc.
-28.57%61.61%-6.92%32.67%24.20%-6.74%-2.67%75.15%
CRWD
CrowdStrike Holdings, Inc.
-16.71%37.00%34.01%142.49%-48.58%-3.34%324.74%-14.02%

Fundamentals

Market Cap

COLL:

$1.31B

CRWD:

$100.78B

EPS

COLL:

$1.60

CRWD:

-$0.73

PS Ratio

COLL:

1.67

CRWD:

20.44

PB Ratio

COLL:

4.35

CRWD:

22.76

Total Revenue (TTM)

COLL:

$780.57M

CRWD:

$4.81B

Gross Profit (TTM)

COLL:

$463.26M

CRWD:

$3.60B

EBITDA (TTM)

COLL:

$599.85M

CRWD:

-$39.16M

Returns By Period

In the year-to-date period, COLL achieves a -28.57% return, which is significantly lower than CRWD's -16.71% return.


COLL

1D
3.38%
1M
-20.64%
YTD
-28.57%
6M
-5.49%
1Y
10.79%
3Y*
11.29%
5Y*
7.18%
10Y*
5.60%

CRWD

1D
2.72%
1M
4.95%
YTD
-16.71%
6M
-20.39%
1Y
10.73%
3Y*
41.69%
5Y*
15.86%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

COLL vs. CRWD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COLL
COLL Risk / Return Rank: 5050
Overall Rank
COLL Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
COLL Sortino Ratio Rank: 4848
Sortino Ratio Rank
COLL Omega Ratio Rank: 4646
Omega Ratio Rank
COLL Calmar Ratio Rank: 4949
Calmar Ratio Rank
COLL Martin Ratio Rank: 5353
Martin Ratio Rank

CRWD
CRWD Risk / Return Rank: 4949
Overall Rank
CRWD Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
CRWD Sortino Ratio Rank: 4747
Sortino Ratio Rank
CRWD Omega Ratio Rank: 4646
Omega Ratio Rank
CRWD Calmar Ratio Rank: 4949
Calmar Ratio Rank
CRWD Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COLL vs. CRWD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Collegium Pharmaceutical, Inc. (COLL) and CrowdStrike Holdings, Inc. (CRWD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


COLLCRWDDifference

Sharpe ratio

Return per unit of total volatility

0.28

0.24

+0.04

Sortino ratio

Return per unit of downside risk

0.70

0.66

+0.04

Omega ratio

Gain probability vs. loss probability

1.08

1.08

0.00

Calmar ratio

Return relative to maximum drawdown

0.32

0.25

+0.07

Martin ratio

Return relative to average drawdown

1.02

0.64

+0.38

COLL vs. CRWD - Sharpe Ratio Comparison

The current COLL Sharpe Ratio is 0.28, which is comparable to the CRWD Sharpe Ratio of 0.24. The chart below compares the historical Sharpe Ratios of COLL and CRWD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


COLLCRWDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.28

0.24

+0.04

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.18

0.32

-0.14

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.10

Sharpe Ratio (All Time)

Calculated using the full available price history

0.16

0.58

-0.42

Correlation

The correlation between COLL and CRWD is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

COLL vs. CRWD - Dividend Comparison

Neither COLL nor CRWD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

COLL vs. CRWD - Drawdown Comparison

The maximum COLL drawdown since its inception was -73.59%, which is greater than CRWD's maximum drawdown of -67.69%. Use the drawdown chart below to compare losses from any high point for COLL and CRWD.


Loading graphics...

Drawdown Indicators


COLLCRWDDifference

Max Drawdown

Largest peak-to-trough decline

-73.59%

-67.69%

-5.90%

Max Drawdown (1Y)

Largest decline over 1 year

-35.81%

-37.18%

+1.37%

Max Drawdown (5Y)

Largest decline over 5 years

-43.99%

-67.69%

+23.70%

Max Drawdown (10Y)

Largest decline over 10 years

-65.22%

Current Drawdown

Current decline from peak

-33.65%

-29.98%

-3.67%

Average Drawdown

Average peak-to-trough decline

-31.16%

-23.92%

-7.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.09%

14.48%

-3.39%

Volatility

COLL vs. CRWD - Volatility Comparison

The current volatility for Collegium Pharmaceutical, Inc. (COLL) is 11.70%, while CrowdStrike Holdings, Inc. (CRWD) has a volatility of 13.51%. This indicates that COLL experiences smaller price fluctuations and is considered to be less risky than CRWD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


COLLCRWDDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.70%

13.51%

-1.81%

Volatility (6M)

Calculated over the trailing 6-month period

27.82%

31.04%

-3.22%

Volatility (1Y)

Calculated over the trailing 1-year period

39.31%

45.40%

-6.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

40.24%

50.18%

-9.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

54.39%

55.93%

-1.54%

Financials

COLL vs. CRWD - Financials Comparison

This section allows you to compare key financial metrics between Collegium Pharmaceutical, Inc. and CrowdStrike Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B1.40BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
205.45M
1.31B
(COLL) Total Revenue
(CRWD) Total Revenue
Values in USD except per share items

COLL vs. CRWD - Profitability Comparison

The chart below illustrates the profitability comparison between Collegium Pharmaceutical, Inc. and CrowdStrike Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
62.5%
75.8%
Portfolio components
COLL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Collegium Pharmaceutical, Inc. reported a gross profit of 128.38M and revenue of 205.45M. Therefore, the gross margin over that period was 62.5%.

CRWD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, CrowdStrike Holdings, Inc. reported a gross profit of 989.46M and revenue of 1.31B. Therefore, the gross margin over that period was 75.8%.

COLL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Collegium Pharmaceutical, Inc. reported an operating income of 59.22M and revenue of 205.45M, resulting in an operating margin of 28.8%.

CRWD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, CrowdStrike Holdings, Inc. reported an operating income of -6.90M and revenue of 1.31B, resulting in an operating margin of -0.5%.

COLL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Collegium Pharmaceutical, Inc. reported a net income of 16.96M and revenue of 205.45M, resulting in a net margin of 8.3%.

CRWD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, CrowdStrike Holdings, Inc. reported a net income of 38.69M and revenue of 1.31B, resulting in a net margin of 3.0%.